Atul Dandekar, CSBO at Maze Therapeutics, Inc. (MAZE), sold 7,500 shares at $28.02 ($210K) on 2026-06-29, disclosed to the SEC on 2026-07-01.
Scheduled sale ($210k) by CSBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MAZE | SELL | 2026-08-31 | $207K | — | Filing → |
| MAZE | SELL | 2026-07-31 | $205K | — | Filing → |
| MAZE | SELL | 2026-06-02 | $198K | — | Filing → |